Connect with us

JAMMU & KASHMIR

DAK skeptical of Russian COVID-19 vaccine | KNO

Published

on

kno news

Srinagar, Aug 12 (KNO): While Russia has approved the world’s first COVID-19 vaccine for public use, Doctors Association Kashmir (DAK) on Wednesday said they are skeptical about the claim as the vaccine has been granted license for civilian use even before the clinical trials are completed. “Mass vaccination with an incompletely tested vaccine is unethical,” said DAK President and influenza expert Dr Nisar ul Hassan in a statement issued to the news agency—Kashmir News Observer (KNO). “Russia has conducted just two trials of the vaccine with the third clinical trial yet to start,” he said. “The normal approval process of a new vaccine is to gather data from phase 1 and phase 2 clinical trials and then expand the pool of study participants in phase 3 to create enough evidence that the vaccine is effective and safe. Dr Nisar said to fully assess the efficacy and safety of a vaccine phase 3 trials are required. “The phase 3 trial is the pivotal study on which the decision on whether to grant the license is based,” he said. He said Russia has not made data from the earlier trials public and the data has not been peer-reviewed which is important for regulatory approval. “Lack of published data on vaccine - including how it is made and details on safety, immune response and whether it can prevent COVID-19 infection has left health experts and the public across the globe in dark,” he added. Dr Nisar said the rush to start using the vaccine before phase 3 trials, which normally lasts for months and involve thousands of people could backfire. “One of the biggest concerns about approving a new vaccine before clinical trials are complete is that it could jeopardize public trust in the vaccine development process and people may not use it,” he said. “Even the Moscow-based Association of Clinical Trials Organization, a trade body representing the world’s top drug makers in Russia had urged the Russian health ministry to postpone vaccine approval until the final trial is successfully completed. The World Health Organization has made it clear that any WHO stamp of approval on Russia’s COVID-19 vaccine would require a rigorous safety data review,” said Dr Nisar—(KNO) 

Trending

TOP STORIES6 hours ago

Kashmir braces for rain, snow as Gulmarg, Pahalgam shiver at -3.5°C | KNO

TOP STORIES6 hours ago

Harud Festival showcases Kashmir’s rich cultural heritage at Gulmarg | KNO

TOP STORIES6 hours ago

AIMSA sets Nov 18 deadline on PG residents’ stipend revision | KNO

TOP STORIES6 hours ago

CAG flags Rs 4.17 lakh tax irregularity involving Srinagar-based firm under Vivad Se Vishwas Scheme | KNO

TOP STORIES6 hours ago

J&K Govt approves Rs 22.71 crore to revive stalled Batamaloo Mini Secretariat | KNO

TOP STORIES6 hours ago

FDA conducts 108 inspections across J&K, suspends licences of three establishments | KNO

TOP STORIES6 hours ago

Kulgam Terror Attack: Courage displayed by jawans foiled nefarious designs of terrorists: Special DG CRPF | KNO

TOP STORIES6 hours ago

CRPF T20 Cricket Cup kicks off in Srinagar, 16 teams in fray | KNO

TOP STORIES6 hours ago

Govt notifies new timing for Kashmir schools | KNO

TOP STORIES6 hours ago

Guns no longer roar in every lane of Kashmir: BJP leader | KNO

TOP STORIES7 hours ago

Govt notifies new timing for Kashmir schools | KNO

TOP STORIES7 hours ago

623 MW power deficit likely during peak winters in J&K, Ladakh | KNO

TOP STORIES7 hours ago

44 Percent consultant posts, 25 Percent medical officer posts vacant in J&K healthcare institutions | KNO

TOP STORIES7 hours ago

Finance Department tells departments to ensure timely payment of electricity dues | KNO

TOP STORIES7 hours ago

Minister Sakina Itoo talks tough on food safety violations | KNO

TOP STORIES7 hours ago

Non-gazetted employees of 5 new GMCs resume protest over non-finalisation of service rules | KNO

TOP STORIES7 hours ago

LoP Sharma seeks S-VYASA’s support to tackle drug menace in J&K | KNO

Copyright © 2021